Kentucky Risperdal Lawsuit Settles for $15.5 Million

Kentucky Risperdal Lawsuit Settles for $15.5 Million

A lawsuit brought by the Kentucky Attorney General alleging that Janssen Pharmaceuticals, the manufacturer of the antipsychotic drug Risperdal, marketed the medication as an appropriate treatment for dementia in non-schizophrenic elderly patients has been settled for $15.5 million.

Risperdal causes male breast growth

According to court documents, Janssen Pharmaceuticals even went so far as to establish an elder care sales force, despite the fact that the company’s own study conducted in 1997 showed that Risperdal actually doubled the risk of death among the elderly.

Risperdal’s label did not disclose this risk to the public until 2003, and in 2013, Janssen pleaded guilty to federal charges of misbranding the drug regarding the promotions to the elderly.

The lawsuit alleged that Janssen did not disclose the risks associated with Risperdal to consumers, and also marketed the drug for uses other than those that were originally approved by the U.S. Food and Drug Administration (FDA), resulting in excessive costs to Medicare and Medicaid in the state.

Table of Contents

What is Risperdal?

Risperdal is an anti-psychotic drug first approved by the U.S. Food and Drug Administration in 1993 to treat adults with schizophrenia.

In 2006 and 2007, the FDA approved additional uses for Risperdal, including the treatment of bipolar disorder in adults and juveniles, schizophrenia in children, and certain behavioral symptoms in children with autism.

The Kentucky lawsuit alleged that even though Risperdal was approved for use in children with Attention Deficit Hyperactivity Disorder (ADHD) in 2007, Janssen actively marketed Risperdal to children and the youth market long before the medication was formally approved for that category of patients.

One Risperdal side effect that has occurred in young males is Risperdal gynecomastia, the development of male breasts stemming from a hormonal imbalance triggered by Risperdal.

Risperdal lawsuits brought by males who claim that their Risperdal prescription caused them to develop gynecomastia continue to be filed and move through courts across the U.S.

Written By:
Jessie Paluch
Jessie Paluch

Experienced Attorney & Legal SaaS CEO

With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three.  She spent the first decade of her career working as an international tax attorney at Deloitte.

In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.

In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!

Camp Lejeune Lawsuit

Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.

Tylenol Lawsuit

Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.

AFFF Lawsuit

Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.

Do You
Have A Case?

Here, at TruLaw, we’re committed to helping victims get the justice they deserve.

Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

Helpful Sites & Resources